The extent of drug therapy for attention deficit-hyperactivity disorder among children in public schools

被引:120
作者
LeFever, GB
Dawson, KV
Morrow, AL
机构
[1] Childrens Hosp Kings Daughters, Ctr Pediat Res, Eastern Virginia Med Sch, Norfolk, VA USA
[2] Childrens Hosp Kings Daughters, Sch & Learning Disorders Program, Norfolk, VA USA
关键词
D O I
10.2105/AJPH.89.9.1359
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objectives. The purpose of this study was to determine the extent of medication use for attention deficit-hyperactivity disorder (ADHD) in south-eastern Virginia. Methods. Students enrolled in grades 2 through 5 in school districts in city A (n = 5767 students) and city B (n = 23 967 students) were included. Nurses recorded students who received ADHD medication in school. Results. The proportion of students receiving ADHD medication was similar in both cities (8% and 10%) and was 2 to 3 times as high as the expected rate of ADHD. Receipt of drug therapy was associated with social and educational characteristics. Medication was used by 3 times as many boys as girls and by twice as many Whites as Blacks. Medication use increased with fears in school. and by fifth grade 18% to 20% of White boys were receiving ADHD medication. Being young for one's grade was positively associated with medication use (P < .01). The prevalence of ADHD was 12% in district A, 63% in district B. Conclusions. These findings suggest that criteria for diagnosis of ADHD vary substantially across US populations, with potential overdiagnosis and overtreatment of ADHD in some groups of children.
引用
收藏
页码:1359 / 1364
页数:6
相关论文
共 40 条
[1]  
Barkley R.A., 1990, Attention-deficit hyperactivity disorder: A handbook for diagnosis and treatment
[2]  
BIRD HR, 1988, ARCH GEN PSYCHIAT, V45, P1120
[3]   ASSOCIATION BETWEEN ATTENTION-DEFICIT HYPERACTIVITY DISORDER AND LEARNING-DISORDERS [J].
CANTWELL, DP ;
BAKER, L .
JOURNAL OF LEARNING DISABILITIES, 1991, 24 (02) :88-95
[4]  
CLAY RA, 1997, AM PSYCHOL ASS MON, P1
[5]   AN EPIDEMIOLOGIC-STUDY OF DISORDERS IN LATE CHILDHOOD AND ADOLESCENCE .1. AGE-SPECIFIC AND GENDER-SPECIFIC PREVALENCE [J].
COHEN, P ;
COHEN, J ;
KASEN, S ;
VELEZ, CN ;
HARTMARK, C ;
JOHNSON, J ;
ROJAS, M ;
BROOK, J ;
STREUNING, EL .
JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY, 1993, 34 (06) :851-867
[6]  
COSTELLO EJ, 1988, ARCH GEN PSYCHIAT, V45, P1107
[7]   EPIDEMIOLOGY AND COURSE OF PSYCHIATRIC-DISORDERS IN SCHOOL-AGE-CHILDREN - RESULTS OF A LONGITUDINAL-STUDY [J].
ESSER, G ;
SCHMIDT, MH ;
WOERNER, W .
JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY AND ALLIED DISCIPLINES, 1990, 31 (02) :243-263
[8]   Open-label treatment of comorbid depression and attentional disorders with co-administration of serotonin reuptake inhibitors and psychostimulants in children, adolescents, and adults: A case series [J].
Findling, RL .
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 1996, 6 (03) :165-175
[9]   Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents [J].
Goldman, LS ;
Genel, M ;
Bezman, RJ ;
Slanetz, PJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (14) :1100-1107
[10]  
GORDON M, 1997, ADHP REP, V5, P1